You just read:

Blueprint Medicines Announces Proof-of-Concept Data from Phase 1 Clinical Trial of BLU-285 in Patients with Advanced Systemic Mastocytosis

News provided by

Blueprint Medicines

Dec 04, 2016, 19:30 ET